FilingSEC EDGARS-8
Artiva Biotherapeutics files Form S-8 registration statement for equity incentive plan
· SEC accepted
StageOngoing
Filing content
The company filed a Form S-8 to increase the number of shares available for issuance under its 2024 Equity Incentive Plan.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…